CAMK2G and cardiac hypertrophy: Similarly, much of the evidence that calcineurin induces pathological cardiac hypertrophy with adverse remodeling and heart failure comes from studies that used forced overexpression of a truncated CnA construct that was deficient in the regulatory domain that CaMKII phosphorylates to inhibit calcineurin (Molkentin, 2013).